← Leaderboards
George E Fisher
Stanford University
$92,253
Attributed
$92,253
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $38.7K · FY2005–08$50K$37.5K$25K$12.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$92,253 · 7
By mechanism
M01$92,253 · 7
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Calvin J Kuo$48,363,495
- Joseph C Wu$80,370,369
- Vinicio A De Jesus Perez$12,110,754
- Shan X. Wang$16,205,138
- Yunzhi Yang$11,928,757
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthSafetyResourcesTumorDoseCapecitabineInstitutionResearch PersonnelSourceToxic EffectGrantCapecitabine/OxaliplatinFundingClinical Trials, Phase IiColorectal CancerComputer Retrieval Of Information On Scientific Projects DatabaseOxaliplatinProtocols, TreatmentCancer PatientClinical TrialsCetuximabAstheniaFluoropyrimidineDiarrhea
Grant awards (7)
CLINICAL TRIAL: STUDY OF CAPECITABINE, OXALIPLATIN AND BEVACIZUMAB FOR METASTATI$11,036
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: RADIATION THERAPY FOLLOWED BY SURGICAL RESECTION FOR RECTAL CANC$4,665
M01 · FY2008 · RR · contact PI
RADIATION THERAPY THEN SURGICAL RESECTION FOR RECTAL CANCER$22,821
M01 · FY2007 · RR · contact PI
RADIATION THERAPY FOLLOWED BY SURGICAL RESECTION FOR RECTAL CANCER$37,362
M01 · FY2006 · RR · contact PI
IMATINIB MESYLATE-RESISTANT OR INTOLERANT MALIGNANT GASTROINTESTINAL TUMOR$1,334
M01 · FY2006 · RR · contact PI
RADIATION THERAPY FOLLOWED BY SURGICAL RESECTION FOR RECTAL CANCER$13,699
M01 · FY2005 · RR
IMATINIB MESYLATE-RESISTANT OR INTOLERANT MALIGNANT GASTROINTESTINAL TUMOR$1,336
M01 · FY2005 · RR